Osimertinib Market Insights Video

According to Cognitive Market Research, the global Osimertinib Market size is USD 4969.02 million in 2024 and will expand at a compound annual growth rate (CAGR) of 16.00% from 2024 to 2031.

• North America held the major market of more than 40% of the global revenue with a market size of USD 1987.61 million in 2024 and will grow at a compound annual growth rate (CAGR) of 14.2% from 2024 to 2031.
• Europe accounted for a share of over 30% of the global market size of USD 1490.71 million.
• Asia Pacific held the market of around 23% of the global revenue with a market size of USD 1142.87 million in 2024 and will grow at a compound annual growth rate (CAGR) of 18.0% from 2024 to 2031.
• Latin America market of more than 5% of the global revenue with a market size of USD 248.45 million in 2024 and will grow at a compound annual growth rate (CAGR) of 15.4% from 2024 to 2031.
• Middle East and Africa held the major market of around 2% of the global revenue with a market size of USD 99.38 million in 2024 and will grow at a compound annual growth rate (CAGR) of 15.7% from 2024 to 2031.
• The Metastatic NSCLC held the highest Osimertinib Market revenue share in 2024